Breed Reply launches latest pan-European search for early stage IoT businesses
5.2.2018 11:00:00 EET | Business Wire | Press release
Breed Reply, a leading active operational investor in early-stage internet of things (IoT) businesses, has today launched a new Europe-wide search for IoT investment opportunities. It is the seventh time Breed Reply has run its “Best in Breed” programme where start-ups with exciting IoT innovations and products are invited to apply to Breed Reply with their investment cases. The best will receive funding along with advisory and support services from Breed Reply.
Successful applicants will pitch to a team with significant experience in scaling up early-stage businesses, in-depth understanding of different markets, proven track record in sales channel development and strong technological DNA.
Providing support as well as funding, is a crucial part of Breed Reply’s commitment to companies when it invests. As an active operational investor, Breed Reply’s role is to work closely with early stage businesses and help with their development and readiness for future funding. Last year one-third of Breed Reply’s 18-strong portfolio of investment companies raised in total more than $50 million in Series A funding from leading investors.
Many of Breed Reply’s growing portfolio of investments across a range of sectors and countries were discovered through previous “Best in Breed” programmes, first launched in 2014, including:
| Canard Drones (Drones, Spain) | Inova Design (Health & Wellness, UK) | ||
| Cocoon (Smart Home, UK) | Kokoon (Wellness, UK) | ||
| Connecterra (AgriTech, The Netherlands) | RazorSecure (Cybersecurity, UK) | ||
| enModus (Smart Buildings, UK) | Senseye (Industrial IoT, UK) | ||
| Gymcraft (Wellness, Spain) | Sentryo (Industrial Security, France) | ||
| Iotic Labs (IoT Platform, UK) |
Wearable Technologies (Industrial Health & Safety, UK) |
Emanuele Angelidis, CEO of Breed Reply, said: “Best in Breed has proved a brilliant way to find innovative IoT start-ups that can disrupt sectors and industries across Europe. Since our first Best in Breed, we have helped lots of companies accelerate their growth and attract even more funding from major investors. We are excited about who we will get to meet this time. Successful applicants typically have a combination of great people, a technology that actually solves a market problem along with a sustainable and scalable business model.”
Companies with an innovative product or service in the IoT space are invited to submit an application to Best in Breed 7 via the Breed Reply website at www.breedreply.com . The closing date for submissions is 16 March 2018.
-ENDS-
About
Breed
Reply
Breed Reply, Reply's active operational investor, funds
and supports the development of early-stage companies in the Internet of
Things (IoT) in Europe and the USA. Based in London, with operational
offices in Germany and Italy, Breed Reply supports entrepreneurs and
young talent by quickly bringing new ideas to the market. This is done
via three fundamental services: funding at early-stage level; active
operational involvement with significant know how transfer of business,
managerial and technological expertise; and go-to market support through
the extensive Reply network. Breed Reply focuses on Health, Fitness &
Wellness, Smart Building & Cities, Security, Industrial IoT, Big Data,
Platforms and Drones.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180205005067/en/
Contact information
Redleaf Communications for Breed Reply
Robin Tozer / Ian Silvera
+44(0)20
3757 6865
breed@redleafpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*13.11.2026 00:07:00 EET | Press release
The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience brings Percy Jackson’s adventures off the screen and into the ‘World’s Most Famous Building,’ where guests ca
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 19:09:00 EET | Press release
VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks to regulatory approval. To remove this barrier, Veristat uses its AI-enhanced platform to compress the timeline to submission-ready TLFs from weeks to days, with every output validated by stati
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 19:00:00 EET | Press release
WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever launched. Every account represents a real person with a verified heartbeat. They have real goals, challenges, and achievements. T
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 18:00:00 EET | Press release
The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and quantum chemistry to embed safety into chemical design from the outset. Adaptive catalytic systems: Led by the Max Planck Insti
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 17:00:00 EET | Press release
Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical applications. As India continues to play a critical role in supplying medicines to patients around the world, pharmaceutical manufacturers face increasing demands for quality, regulatory compliance,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom